New rules would change how hemp products are made, sold, and taxed, and allow Medicare coverage.
This bill would set new federal rules for hemp-derived products, changing what counts as legal hemp and how these products are regulated by the FDA. It would also add new taxes on these products and require states to adopt strict impaired driving laws for hemp. For some, it would allow Medicare to cover certain hemp products.
Currently, the legal definition of hemp allows for a total THC concentration of 0.3%. There are varying state-level regulations for hemp-derived cannabinoid products, and federal oversight by the FDA is limited. There are no specific federal taxes on these products, and Medicare generally does not cover them. States have different approaches to impaired driving laws related to hemp. If this bill becomes law, the legal THC limit for hemp would increase to 1%, but many synthetic cannabinoids would become illegal. The FDA would gain significant authority, setting age limits (21+), mandating detailed labels, establishing maximum cannabinoid content, and requiring uniform manufacturing and testing. All products would need to be fully U.S.-sourced. New federal taxes would be imposed: 5 cents per milligram of THC for beverages, 5% of the sales price for other products, and a 5% sales revenue tax for manufacturers. A three-tiered distribution system would be created for hemp beverages. States would be required to implement "zero tolerance" impaired driving laws for hemp, with penalties similar to alcohol, or face a 10% cut in federal highway funds. Medicare Advantage plans would be allowed to offer coverage for hemp-derived cannabinoid products as a supplemental benefit for the chronically ill.
HR 9830 · 119th Congress · July 22, 2026 · AI Summary by gemini-2.5-flash · 8/10
Sign in to see your representatives' phone numbers